Skip to main content

Table 2 Baseline patient characteristics by SBP target group

From: Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry

Baseline characteristic

All subjects (n = 8,632*)

SBP ≤ 130 mmHg (n = 3,342)

SBP > 130 to ≤ 135 mmHg (n = 2,870)

SBP > 135 to ≤ 140 mmHg (n = 2,384)

P-values for the comparison of 3 groups

Age (years)

65.0 (57.0-74.0)

64.0 (55.0-72.0)

66.0 (58.0-74.0)

68.0 (59.0-75.0)

<0.0001

Age > 75 years (%)

19.7

16.7

20.5

22.8

<0.0001

Female sex (%)

45.6

46.1

44.8

45.5

0.59

BMI (kg/m2)

31.2 ± 5.9

31.1 ± 5.8

31.2 ± 5.7

31.4 ± 6.1

0.48

BMI > 30 kg/m2 (%)

52.0

51.4

51.8

52.9

0.53

Waist circumference (cm)

107.6 ± 14.5

107.8 ± 15.1

107.4 ± 13.7

107.5 ± 14.8

0.68

Current smokers (%)

11.8

12.1

11.5

11.6

0.77

Diabetes duration (months)

67.9 (31.7-117.3)

61.4 (27.6-109.7)

71.2 (34.1-120.2)

72.7 (34.1-121.1)

<0.0001

Fasting glucose (mmol/l)

8.5 ± 2.8

8.2 ± 2.7

8.7 ± 2.8

8.8 ± 2.9

<0.0001

Postprandial glucose (mmol/l)

10.9 ± 3.4

10.5 ± 3.2

11.2 ± 3.4

11.1 ± 3.6

<0.0001

HbA1c (%)

7.8 ± 2.1

7.5 ± 1.4

7.9 ± 1.4

8.1 ± 3.4

<0.0001

SBP (mmHg)

140.3 ± 15.7

136.4 ± 15.5

140.7 ± 14.8

145.2 ± 15.4

<0.0001

 ≤ 130 mmHg (%)

32.0

45.2

28.1

17.8

<0.0001

 > 130 to ≤ 135 mmHg (%)

9.2

8.8

12.4

5.8

<0.0001

 > 135 to ≤ 140 mmHg (%)

21.7

18.2

22.4

26.1

<0.0001

DBP (mmHg)

82.6 ± 9.5

81.3 ± 9.5

82.9 ± 9.1

84.1 ± 9.7

<0.0001

HR (beats/min)

75.0 ± 10.0

74.5 ± 10.0

75.2 ± 10.2

75.6 ± 10.2

<0.0001

  1. Legend: SBP, systolic blood pressure; BMI, body mass index; HbA1c, glycated hemoglobin; DBP, diastolic blood pressure; HR, heart rate; *for 36 patients no SBP target was indicated; data are provided as medians (interquartile range), percent or mean ± standard deviation.